Masahiro Tanaka

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi Trends in pertussis among infants in the United States, 1980-1999
    Masahiro Tanaka
    Bacterial Vaccine Preventable Disease Branch, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    JAMA 290:2968-75. 2003
  2. ncbi Immunological evaluation of personalized peptide vaccination with gemcitabine for pancreatic cancer
    Hiroaki Yanagimoto
    Department of Surgery, Kansai Medical University, 2 3 1 Shinmachi, Hirakata, Osaka 573 1191, Japan
    Cancer Sci 98:605-11. 2007

Collaborators

  • F Brian Pascual
  • Hiroaki Yanagimoto
  • Akira Yamada
  • Soichiro Takai
  • Yasuo Kamiyama
  • Junko Mizoguchi
  • Takashi Mine
  • Kanji Takahashi
  • Koutaro Yamamoto
  • Kimika Nakahara
  • Shigenori Honma
  • Naoyoshi Terakawa
  • Sohei Satoi
  • Kyogo Itoh
  • Masaaki Oka

Detail Information

Publications2

  1. ncbi Trends in pertussis among infants in the United States, 1980-1999
    Masahiro Tanaka
    Bacterial Vaccine Preventable Disease Branch, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    JAMA 290:2968-75. 2003
    ..However, severe pertussis morbidity and mortality occur primarily among infants...
  2. ncbi Immunological evaluation of personalized peptide vaccination with gemcitabine for pancreatic cancer
    Hiroaki Yanagimoto
    Department of Surgery, Kansai Medical University, 2 3 1 Shinmachi, Hirakata, Osaka 573 1191, Japan
    Cancer Sci 98:605-11. 2007
    ..GEM did not inhibit the immune responses induced by personalized peptide vaccinations, and this new type of immunochemotherapy combination is recommended for further clinical study in APC patients...